What is the recommended treatment for internal carotid artery stenosis?

Treatment for Internal Carotid Stenosis

For symptomatic patients with ≥70% stenosis, carotid endarterectomy (CEA) should be performed within 2 weeks of the ischemic event, with carotid artery stenting (CAS) as an alternative in younger patients (<70 years) or those with unfavorable neck anatomy. 1

Symptomatic Carotid Stenosis (Recent TIA or Stroke)

High-Grade Stenosis (≥70%)

• CEA is the primary recommendation for patients at average or low surgical risk when stenosis is >70% by noninvasive imaging or >50% by catheter angiography, with anticipated perioperative stroke/mortality <6% 1
• Timing is critical: Perform revascularization within 2 weeks of the index event rather than delaying 1
• CAS is an acceptable alternative when stenosis is >70% by noninvasive imaging or >50% by catheter angiography, particularly in:
  • Patients <70 years old 2
  • Those with unfavorable neck anatomy for surgery 1
  • When anticipated periprocedural stroke/mortality is <6% 1

Moderate Stenosis (50-69%)

• CEA is recommended for symptomatic patients with 50-69% stenosis, though with slightly less certainty than for higher-grade stenosis 1
• CAS may be considered in younger patients with appropriate anatomy 2

Mild Stenosis (<50%)

• Revascularization is NOT recommended except in extraordinary circumstances 1
• Focus on optimal medical therapy alone

Asymptomatic Carotid Stenosis

Recent Evidence Shift

The 2025 CREST-2 trial has fundamentally changed the landscape: adding CAS to optimal medical therapy (OMT) showed modest benefit (2.8% vs 6.0% 4-year stroke rate, p=0.02), while adding CEA to OMT did not reach statistical significance (3.7% vs 5.3%, p=0.24) 3. This represents a paradigm shift from historical practice.

High-Grade Stenosis (≥70%)

• CEA is reasonable if perioperative stroke/MI/death risk is low, but patient selection must be rigorous 1
• CAS might be considered for highly selected patients with ≥60% stenosis by angiography or ≥70% by validated duplex ultrasound, though effectiveness versus medical therapy alone is not well established 1
• Critical caveat: The ECST-2 interim analysis showed no benefit of revascularization added to OMT in asymptomatic or low-to-intermediate-risk symptomatic patients 3

Patient Selection Factors

Selection should be guided by:

• Comorbid conditions and life expectancy
• Individual stroke risk factors
• Thorough discussion of risks versus benefits 1

Medical Management (Universal for All Patients)

All patients with significant carotid stenosis require intensive medical therapy regardless of whether revascularization is performed 4:

Lipid Management

• Intensive statin therapy targeting LDL-C <55 mg/dL 4
• Add ezetimibe or PCSK9 inhibitor if target not achieved

Antiplatelet Therapy

• Single antiplatelet agent (aspirin or clopidogrel) for stable disease 4
• Ticagrelor superior to aspirin in patients with ipsilateral atherosclerotic stenosis after acute ischemic stroke/TIA (HR 0.68,95% CI 0.53-0.88) 4
• Dual antiplatelet therapy (DAPT) peri-procedurally:
  • For CEA: Continue DAPT peri-procedurally, reduce to single agent from day 1 post-CEA for 1-3 months 4
  • For CAS: Clopidogrel loading pre-stenting, continue DAPT for 1-3 months post-stenting (4-6 weeks for single-layer stents, up to 3 months for mesh stents) 4

Blood Pressure Control

• Antihypertensive medications per standard cardiovascular prevention guidelines 4

Lifestyle Modifications

• Smoking cessation
• Weight loss and regular exercise
• Balanced diet (higher quality diet associated with 14% stroke reduction) 4

Procedural Considerations

CEA Preferred When:

• Older patients 1
• Unfavorable arterial pathoanatomy for endovascular intervention 1

CAS Preferred When:

• Younger patients (<70 years) 2
• Unfavorable neck anatomy for surgery 1
• Technological advances with double-layer stents improve safety 5

Contraindications to Revascularization

Do NOT perform revascularization in 1:

• Chronic total occlusion of the carotid artery
• Severe disability from cerebral infarction precluding preservation of useful function
• Stenosis <50% (except extraordinary circumstances)

Common Pitfalls

• Delaying surgery in symptomatic patients: The stroke risk is highest immediately after the index event—intervene within 2 weeks 1
• Over-treating asymptomatic stenosis: Modern medical therapy has dramatically reduced stroke risk; revascularization benefit is modest at best and requires careful patient selection 3
• Ignoring perioperative risk: Only proceed if anticipated perioperative stroke/mortality is <6% 1
• Using PSV alone for stenosis grading: Incorporate end-diastolic velocity and ICA/CCA ratio to avoid misclassification 6